Drug Discount Cards Considered "Not Worth The Trouble" By Most Seniors, Kaiser Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The majority of Medicare beneficiaries say the program's approved drug discount cards "aren't worth the trouble" of enrolling, according to Kaiser Family Foundation/Harvard School of Public Health survey results released Aug. 10
You may also be interested in...
Medicare Rx Seen As Helpful By 33% Of Low-Income Seniors – Kaiser Survey
Results of a Kaiser Family Foundation/Harvard School of Public Health survey also show about a third of the overall Medicare population believes the drug benefit will help them personally. Almost half of respondents had an unfavorable view of the law.
Overall Drug Discount Card Prices Have Remained Steady – Kaiser Study
The researchers note that card sponsors could choose to significantly alter pricing strategies during the fall open-enrollment period. Four million Medicare beneficiaries have signed up for cards.
Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability